Literature DB >> 31482575

Managing Increased Accessibility to Pharmacogenomic Data.

Susanne B Haga1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31482575      PMCID： PMC6778003          DOI： 10.1002/cpt.1602

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  10 in total

1.  Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.

Authors:  Susanne B Haga; Ariel Kantor
Journal:  Health Aff (Millwood)       Date:  2018-05       Impact factor: 6.301

2.  An ancillary genomics system to support the return of pharmacogenomic results.

Authors:  Luke V Rasmussen; Maureen E Smith; Federico Almaraz; Stephen D Persell; Laura J Rasmussen-Torvik; Jennifer A Pacheco; Rex L Chisholm; Carl Christensen; Timothy M Herr; Firas H Wehbe; Justin B Starren
Journal:  J Am Med Inform Assoc       Date:  2019-04-01       Impact factor: 4.497

Review 3.  Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists.

Authors:  Victoria M Pratt; Larisa H Cavallari; Andria L Del Tredici; Houda Hachad; Yuan Ji; Ann M Moyer; Stuart A Scott; Michelle Whirl-Carrillo; Karen E Weck
Journal:  J Mol Diagn       Date:  2019-05-08       Impact factor: 5.568

4.  Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.

Authors:  Chad A Bousman; Philip Jaksa; Christos Pantelis
Journal:  Pharmacogenet Genomics       Date:  2017-11       Impact factor: 2.089

Review 5.  Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions.

Authors:  Michelle E Klein; Md Masud Parvez; Jae-Gook Shin
Journal:  J Pharm Sci       Date:  2017-06-13       Impact factor: 3.534

Review 6.  Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.

Authors:  Henry M Dunnenberger; Kristine R Crews; James M Hoffman; Kelly E Caudle; Ulrich Broeckel; Scott C Howard; Robert J Hunkler; Teri E Klein; William E Evans; Mary V Relling
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-02       Impact factor: 13.820

7.  Implications of the Human Genome Project for medical science.

Authors:  F S Collins; V A McKusick
Journal:  JAMA       Date:  2001-02-07       Impact factor: 56.272

8.  Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

Authors:  P H O'Donnell; N Wadhwa; K Danahey; B A Borden; S M Lee; J P Hall; C Klammer; S Hussain; M Siegler; M J Sorrentino; A M Davis; Y A Sacro; R Nanda; T S Polonsky; J L Koyner; D L Burnet; K Lipstreuer; D T Rubin; C Mulcahy; M E Strek; W Harper; A S Cifu; B Polite; L Patrick-Miller; K-Tj Yeo; Eky Leung; S L Volchenboum; R B Altman; O I Olopade; W M Stadler; D O Meltzer; M J Ratain
Journal:  Clin Pharmacol Ther       Date:  2017-06-15       Impact factor: 6.875

Review 9.  Pharmacogenetics: a general review on progress to date.

Authors:  Ann K Daly
Journal:  Br Med Bull       Date:  2017-12-01       Impact factor: 4.291

10.  Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.

Authors:  Cathelijne H van der Wouden; Mandy H van Rhenen; Wafa O M Jama; Magnus Ingelman-Sundberg; Volker M Lauschke; Lidija Konta; Matthias Schwab; Jesse J Swen; Henk-Jan Guchelaar
Journal:  Clin Pharmacol Ther       Date:  2019-06-12       Impact factor: 6.875
  10 in total
  1 in total

1.  Implementation of Pharmacogenomics and Artificial Intelligence Tools for Chronic Disease Management in Primary Care Setting.

Authors:  Patrick Silva; David Jacobs; John Kriak; Asim Abu-Baker; George Udeani; Gabriel Neal; Kenneth Ramos
Journal:  J Pers Med       Date:  2021-05-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.